Liver transplantation and hepatitis B virus infection: the situation seems to be under control, but the virus is still there

被引:42
作者
Samuel, D [1 ]
机构
[1] Hop Paul Brousse, Fac Med Paris Sud, Ctr HepatoBiliaire, Upres 1596, Paris, France
关键词
D O I
10.1016/S0168-8278(01)00102-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:943 / 945
页数:3
相关论文
共 23 条
[1]
Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation [J].
Bain, VG ;
Kneteman, NM ;
Ma, MM ;
Gutfreund, K ;
Shapiro, JA ;
Fischer, K ;
Tipples, G ;
Lee, H ;
Jewell, LD ;
Tyrrell, DL .
TRANSPLANTATION, 1996, 62 (10) :1456-1462
[2]
Gigou M, 2000, HEPATOLOGY, V32, p218A
[3]
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis [J].
Grellier, L ;
Mutimer, D ;
Ahmed, M ;
Brown, D ;
Burroughs, AK ;
Rolles, K ;
McMaster, P ;
Beranek, P ;
Kennedy, F ;
Kibbler, H ;
McPhillips, P ;
Elias, E ;
Dusheiko, G .
LANCET, 1996, 348 (9036) :1212-1215
[4]
Lowell J A, 1996, Liver Transpl Surg, V2, P475, DOI 10.1002/lt.500020612
[5]
Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin [J].
Markowitz, JS ;
Martin, P ;
Conrad, AJ ;
Markmann, JF ;
Seu, P ;
Yersiz, H ;
Goss, JA ;
Schmidt, P ;
Pakrasi, A ;
Artinian, L ;
Murray, NGB ;
Imagawa, DK ;
Holt, C ;
Goldstein, LI ;
Stribling, R ;
Busuttil, RW .
HEPATOLOGY, 1998, 28 (02) :585-589
[6]
Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis [J].
Marzano, A ;
Salizzoni, M ;
Debernardi-Venon, W ;
Smedile, A ;
Franchello, A ;
Ciancio, A ;
Gentilcore, E ;
Piantino, P ;
Barbui, AM ;
David, E ;
Negro, F ;
Rizzetto, M .
JOURNAL OF HEPATOLOGY, 2001, 34 (06) :903-910
[7]
Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: High resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immune globulin [J].
McCaughan, GW ;
Spencer, J ;
Koorey, D ;
Bowden, S ;
Bartholomeusz, A ;
Littlejohn, M ;
Verran, D ;
Chui, AKK ;
Sheil, AGR ;
Jones, RM ;
Locarnini, SA ;
Angus, PW .
LIVER TRANSPLANTATION AND SURGERY, 1999, 5 (06) :512-519
[8]
Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization [J].
McGory, RW ;
Ishitani, MB ;
Oliveira, WM ;
Stevenson, WC ;
McCullough, CS ;
Dickson, RC ;
Caldwell, SH ;
Pruett, TL .
TRANSPLANTATION, 1996, 61 (09) :1358-1364
[9]
EUROHEP CONSENSUS REPORT AN THE MANAGEMENT OF LIVER-TRANSPLANTATION FOR HEPATITIS-B VIRUS-INFECTION [J].
MULLER, R ;
SAMUEL, D ;
FASSATI, LR ;
BENHAMOU, JP ;
BISMUTH, H ;
ALEXANDER, GJM .
JOURNAL OF HEPATOLOGY, 1994, 21 (06) :1140-1143
[10]
Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient [J].
Mutimer, D ;
Pillay, D ;
Shields, P ;
Cane, P ;
Ratcliffe, D ;
Martin, B ;
Buchan, S ;
Boxall, L ;
O'Donnell, K ;
Shaw, J ;
Hübscher, S ;
Elias, E .
GUT, 2000, 46 (01) :107-113